Innovative Statistics in Regulatory Science Innovative Statistics in Regulatory Science
Chapman & Hall/CRC Biostatistics Series

Innovative Statistics in Regulatory Science

    • 52,99 €
    • 52,99 €

Publisher Description

Statistical methods that are commonly used in the review and approval process of regulatory submissions are usually referred to as statistics in regulatory science or regulatory statistics. In a broader sense, statistics in regulatory science can be defined as valid statistics that are employed in the review and approval process of regulatory submissions of pharmaceutical products. In addition, statistics in regulatory science are involved with the development of regulatory policy, guidance, and regulatory critical clinical initiatives related research. This book is devoted to the discussion of statistics in regulatory science for pharmaceutical development. It covers practical issues that are commonly encountered in regulatory science of pharmaceutical research and development including topics related to research activities, review of regulatory submissions, recent critical clinical initiatives, and policy/guidance development in regulatory science.
Devoted entirely to discussing statistics in regulatory science for pharmaceutical development. Reviews critical issues (e.g., endpoint/margin selection and complex innovative design such as adaptive trial design) in the pharmaceutical development and regulatory approval process. Clarifies controversial statistical issues (e.g., hypothesis testing versus confidence interval approach, missing data/estimands, multiplicity, and Bayesian design and approach) in review/approval of regulatory submissions. Proposes innovative thinking regarding study designs and statistical methods (e.g., n-of-1 trial design, adaptive trial design, and probability monitoring procedure for sample size) for rare disease drug development. Provides insight regarding current regulatory clinical initiatives (e.g., precision/personalized medicine, biomarker-driven target clinical trials, model informed drug development, big data analytics, and real world data/evidence).
This book provides key statistical concepts, innovative designs, and analysis methods that are useful in regulatory science. Also included are some practical, challenging, and controversial issues that are commonly seen in the review and approval process of regulatory submissions.

About the author

Shein-Chung Chow, Ph.D. is currently a Professor at Duke University School of Medicine, Durham, NC. He was previously the Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA). Dr. Chow has also held various positions in the pharmaceutical industry such as Vice President at Millennium, Cambridge, MA, Executive Director at Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers

Squibb, Plainsboro, NJ. He was elected Fellow of the American Statistical Association and an elected member of the ISI (International Statistical Institute). Dr. Chow is Editor-in-Chief of the Journal of Biopharmaceutical Statistics and Biostatistics Book Series, Chapman and Hall/CRC Press, Taylor & Francis, New York. Dr. Chow is the author or co-author of over 300 methodology papers and 30 books.

GENRE
Science & Nature
RELEASED
2019
18 November
LANGUAGE
EN
English
LENGTH
552
Pages
PUBLISHER
CRC Press
SIZE
90.7
MB

More Books by Shein-Chung Chow

Advanced Statistics in Regulatory Critical Clinical Initiatives Advanced Statistics in Regulatory Critical Clinical Initiatives
2022
Methodologies in Biosimilar Product Development Methodologies in Biosimilar Product Development
2021
Advanced Linear Models Advanced Linear Models
2018
Analytical Similarity Assessment in Biosimilar Product Development Analytical Similarity Assessment in Biosimilar Product Development
2018
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Biosimilar Drug Product Development Biosimilar Drug Product Development
2017

Other Books in This Series

Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021
Statistical Thinking in Clinical Trials Statistical Thinking in Clinical Trials
2021
Signal Detection for Medical Scientists Signal Detection for Medical Scientists
2021
Single-Arm Phase II Survival Trial Design Single-Arm Phase II Survival Trial Design
2021
Medical Statistics for Cancer Studies Medical Statistics for Cancer Studies
2022
Analyzing Longitudinal Clinical Trial Data Analyzing Longitudinal Clinical Trial Data
2016